09/2009 - DrÅ¾avni zavod za intelektualno vlasniÅ¡tvo

More documents

Recommendations

Info

3508 HR - Patenti - Hrvatski glasnik intelektualnog vlasništva 16, 2009, 9, 3373 – 3601 MKP Broj objave europske Naziv izuma prijave patenta (51) (97) (54) A61K 31/506 (2006.01) EP 2086965 * AMINOPYRIDINES AND AMINOPYRIMIDINES USEFUL AS INHIBITORS OF PROTEIN KINASES A61K 31/506 (2006.01) EP 2096111 * PYRAZOLES AND USE THEREOF AS DRUGS A61K 31/506 (2006.01) EP 2097084 * CARBOXAMIDE 4-[(4-PYRIDYL)AMINO] PYRIMIDINES FOR THE TREATMENT OF HEPATITIS C A61K 31/506 (2006.01) EP 2097378 * NOVEL SEH INHIBITORS AND THEIR USE A61K 31/506 (2006.01) EP 2097406 * HYDANTOIN DERIVATIVES USED AS MMP INHIBITORS A61K 31/506 (2006.01) EP 2098509 * 1-NAPHTHYL ALKYLPIPERIDINE DERIVATIVE A61K 31/506 (2006.01) EP 2099771 * PYRIMIDINE KINASE INHIBITORS A61K 31/506 (2006.01) EP 2099787 * AMINOPYRIMIDINES USEFUL AS INHIBITORS OF PROTEIN KINASES A61K 31/513 (2006.01) EP 2091941 * MAPK/ERK KINASE INHIBITORS A61K 31/513 (2006.01) EP 2097409 * 2-SUBSTITUTED-6-HETEROCYCLIC PYRIMIDONE DERIVATIVES AS TAU PROTEIN KINASE 1 INHBITORS A61K 31/517 (2006.01) EP 2088862 * CANCER TREATMENT METHOD A61K 31/517 (2006.01) EP 2094270 * DELIVERY SYSTEM FOR RISPERIDONE A61K 31/517 (2006.01) EP 2094272 * NITROGEN CONTAINING SUBSTITUTED HETEROCYCLES AS PLATELET ADP RECEPTOR INHIBITORS A61K 31/517 (2006.01) EP 2094672 * ARYLSULFONAMIDE COMPOUNDS A61K 31/517 (2006.01) EP 2096919 * TREATING HYPER-PROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH ANGIOGENESIS SUBSTITUTED 2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLINE DERIVATIVES USEFUL FOR A61K 31/517 (2006.01) EP 2097390 * AMINO QUINAZOLINES DERIVATIVES WUTH BLOOD PLATELET REDUCING PROPERTIES A61K 31/519 (2006.01) EP 2020410 Pyrido[2,3d]pyrimidine derivatives, process for their preparation and their therapeutical use A61K 31/519 (2006.01) EP 2086533 * USE OF AN ADENOSINE ANTAGONIST A61K 31/519 (2006.01) EP 2086544 * USE OF TESTOSTERONE AND A 5-HT1A AGONIST IN THE TREATMENT OF SEXUAL DYSFUNCTION A61K 31/519 (2006.01) EP 2086545 * USE OF 3-ALPHA-ANDROSTANEDIOL, OPTIONALLY IN COMBINATION WITH A PDE5 INHIBITOR, IN THE TREATMENT OF SEXUAL DYSFUNCTION A61K 31/519 (2006.01) EP 2086548 * USE OF 3-ALPHA-ANDROSTANEDIOL, OPTIONALLY IN COMBINATION WITH A 5-HT1A AGONIST, IN THE TREATMENT OF SEXUAL DYSFUNCTION A61K 31/519 (2006.01) EP 2086979 * IMIDAZOÝ1,2-B¨PYRIDAZINE AND PYRAZOLOÝ1,5-A¨PYRIMIDINE DERIVATIVES AND THEIR USE AS PROTEIN KINASE INHIBITORS A61K 31/519 (2006.01) EP 2089032 * A PHARMACEUTICAL COMPOSITION HAVING ANTIPSYCHOTIC, ANTIDEPRESSANT OR ANTIEPIIEPTIC ACTIVITY WITH REDUCED SIDE EFFECT A61K 31/519 (2006.01) EP 2089392 * 3-(DIHYDRO-1H-PYRAZOLO Ý4,3-D¨PYRIMIDIN-5-YL)-4- PROPOXYBENZENESULFONAMIDE DERIVATIVES AND METHODS OF USE A61K 31/519 (2006.01) EP 2094671 * HETEROBICYCLIC METALLOPROTEASE INHIBITORS A61K 31/519 (2006.01) EP 2099447 * IMIDAZOTRIAZINES AND IMIDAZOPYRIMIDINES AS KINASE INHIBITORS A61K 31/519 (2006.01) EP 2099792 * HETEROTRICYCLIC METALLOPROTEASE INHIBITORS A61K 31/522 (2006.01) EP 2094697 * 5-SULFANYLMETHYL-PYRAZOLO [1,5-A]PYRIMIDIN-7-OL DERIVATIVES AS CXCR2 ANTAGONISTS A61K 31/53 (2006.01) EP 2094707 * HETEROBICYCLIC MATRIX METALLOPROTEASE INHIBITORS A61K 31/53 (2006.01) EP 2097378 * NOVEL SEH INHIBITORS AND THEIR USE A61K 31/53 (2006.01) EP 2099451 * COMBINATION OF AN HDAC INHIBITOR AND AN ANTIMETABOLITE A61K 31/53 (2006.01) EP 2099803 * HETEROBICYCLIC MATRIX METALLOPROTEASE INHIBITORS A61K 31/535 (2006.01) EP 2094254 * TREATMENT OF CACHEXIA A61K 31/5355 (2006.01) EP 2086964 * BENZOYL AMINO HETEROCYCLYL COMPOUNDS USEFUL IN THE TREATMENT OF A DISEASE MEDIATED THROUGH GLK A61K 31/536 (2006.01) EP 2094271 * DRUG COMBINATIONS FOR TREATING AIRWAY DISEASES A61K 31/536 (2006.01) EP 2094272 * NITROGEN CONTAINING SUBSTITUTED HETEROCYCLES AS PLATELET ADP RECEPTOR INHIBITORS A61K 31/536 (2006.01) EP 2094646 * AMINE DERIVATIVES AND THEIR USE IN BETA-2-ADRENORECEPTOR MEDIATED DISEASES A61K 31/5377 (2006.01) EP 2096111 * PYRAZOLES AND USE THEREOF AS DRUGS A61K 31/5377 (2006.01) EP 2098509 * 1-NAPHTHYL ALKYLPIPERIDINE DERIVATIVE A61K 31/549 (2006.01) EP 2094259 * RENIN INHIBITORS FOR THE PREVENTION AND TREATMENT OF HYPERTENSION IN OBESE PATIENTS A61K 31/55 (2006.01) EP 2086981 * COMPOUNDS FOR INHIBITING MITOTIC PROGRESSION A61K 31/55 (2006.01) EP 2091541 * VAGINAL DELIVERY SYSTEM FOR MIRTAZAPINE A61K 31/55 (2006.01) EP 2091926 * SUBSTITUTED PYRAZOLE AND TRIAZOLE COMPOUNDS AS KSP INHIBITORS A61K 31/55 (2006.01) EP 2094246 * SUSTAINED-RELEASE COMPOSITION AND METHOD FOR PRODUCING THE SAME A61K 31/551 (2006.01) EP 2089032 * A PHARMACEUTICAL COMPOSITION HAVING ANTIPSYCHOTIC, ANTIDEPRESSANT OR ANTIEPIIEPTIC ACTIVITY WITH REDUCED SIDE EFFECT A61K 31/551 (2006.01) EP 2089382 * SUBSTITUTED DIAZEPAN COMPOUNDS AS OREXIN RECEPTOR ANTAGONISTS A61K 31/551 (2006.01) EP 2099761 * ANTIBACTERIAL QUINOLINE DERIVATIVES A61K 31/553 (2006.01) EP 2086964 * BENZOYL AMINO HETEROCYCLYL COMPOUNDS USEFUL IN THE TREATMENT OF A DISEASE MEDIATED THROUGH GLK ISSN 1331-2030
HR - Patenti - Hrvatski glasnik intelektualnog vlasništva 16, 2009, 9, 3373 – 3601 3509 MKP Broj objave europske Naziv izuma prijave patenta (51) (97) (54) A61K 31/553 (2006.01) EP 2089024 * COMBINATION OF IAP INHIBITORS AND FLT3 INHIBITORS A61K 31/554 (2006.01) EP 2086964 * BENZOYL AMINO HETEROCYCLYL COMPOUNDS USEFUL IN THE TREATMENT OF A DISEASE MEDIATED THROUGH GLK A61K 31/554 (2006.01) EP 2089032 * A PHARMACEUTICAL COMPOSITION HAVING ANTIPSYCHOTIC, ANTIDEPRESSANT OR ANTIEPIIEPTIC ACTIVITY WITH REDUCED SIDE EFFECT A61K 31/555 (2006.01) EP 2096923 * HETEROARYL AMIDE DERIVATIVES A61K 31/565 (2006.01) EP 2087883 Stabilised supersaturated solid solutions of steroidal drugs A61K 31/566 (2006.01) EP 2097079 * MODULATION OF PROSTAGLANDIN/CYCLOOXYGENASE METABOLIC PATHWAYS A61K 31/568 (2006.01) EP 2086544 * USE OF TESTOSTERONE AND A 5-HT1A AGONIST IN THE TREATMENT OF SEXUAL DYSFUNCTION A61K 31/568 (2006.01) EP 2086545 * USE OF 3-ALPHA-ANDROSTANEDIOL, OPTIONALLY IN COMBINATION WITH A PDE5 INHIBITOR, IN THE TREATMENT OF SEXUAL DYSFUNCTION A61K 31/568 (2006.01) EP 2086548 * USE OF 3-ALPHA-ANDROSTANEDIOL, OPTIONALLY IN COMBINATION WITH A 5-HT1A AGONIST, IN THE TREATMENT OF SEXUAL DYSFUNCTION A61K 31/568 (2006.01) EP 2097079 * MODULATION OF PROSTAGLANDIN/CYCLOOXYGENASE METABOLIC PATHWAYS A61K 31/5685 (2006.01) EP 2097079 * MODULATION OF PROSTAGLANDIN/CYCLOOXYGENASE METABOLIC PATHWAYS A61K 31/57 (2006.01) EP 2094275 * METHODS AND FORMULATIONS FOR IMPROVED BIOAVAILABILITY OF ANTIPROGESTINS A61K 31/57 (2006.01) EP 2097079 * MODULATION OF PROSTAGLANDIN/CYCLOOXYGENASE METABOLIC PATHWAYS A61K 31/585 (2006.01) EP 2087883 Stabilised supersaturated solid solutions of steroidal drugs A61K 31/661 (2006.01) EP 2099768 * AGONISTS OF THE SPHINGOSINE-1-PHOSPHATE RECEPTOR A61K 31/675 (2006.01) EP 2094276 * ANTI-VIRAL COMPOUNDS A61K 31/695 (2006.01) EP 2074135 * SILICON DERIVATIVES FOR PET IMAGING A61K 31/704 (2006.01) EP 2089024 * COMBINATION OF IAP INHIBITORS AND FLT3 INHIBITORS A61K 31/7048 (2006.01) EP 2087104 * MEDIUM SUPPLEMENT FOR VIRUS PRODUCTION A61K 31/7068 (2006.01) EP 2089024 * COMBINATION OF IAP INHIBITORS AND FLT3 INHIBITORS A61K 31/7088 (2006.01) EP 2086533 * USE OF AN ADENOSINE ANTAGONIST A61K 31/7088 (2006.01) EP 2098595 * HLA-A*1101-RESTRICTED WT1 PEPTIDE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME A61K 31/7105 (2006.01) EP 2086533 * USE OF AN ADENOSINE ANTAGONIST A61K 31/7105 (2006.01) EP 2095127 * METHODS FOR SCREENING AND TREATMENT INVOLVING THE GENES GYPC, AGPAT3, AGL, PVRL2, HMGB 3, HSDL2 AND/OR LDB2 A61K 31/711 (2006.01) EP 2097104 * NEW A-BETA CONFORMER SELECTIVE ANTI-A-BETA GLOBULOMER MONOCLONAL ANTIBODIES A61K 31/728 (2006.01) EP 2091529 * USE OF L-CARNITINE FOR THE PREPARATION OF A MEDICAMENT IN THE FORM OF EYE-DROPS FOR TREATING CORNEAL DISEASES A61K 31/728 (2006.01) EP 2099462 * PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF INFLAMMATORY DISEASES OF THE UROGENITAL TRACT A61K 31/737 (2006.01) EP 2099462 * PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF INFLAMMATORY DISEASES OF THE UROGENITAL TRACT A61K 33/00 (2006.01) EP 2088999 * PHARMACEUTICAL COMPOSITION COMPRISING AN ACTIVE INGREDIENT WHICH NEUTRALIZES AND/OR BINDS GASTRIC ACID, SUCH AS AN ALGINIC ACID DERIVATIVE A61K 33/06 (2006.01) EP 2089046 * ANTIDIABETOGENIC CALCIUM-PEPTIDE COMPOSITION A61K 35/00 (2006.01) EP 2094282 * ANTI-TSG101 ANTIBODIES AND THEIR USES FOR TREATMENT OF VIRAL INFECTIONS A61K 35/14 (2006.01) EP 2089041 * METHODS FOR USING ALDHBR CELLS TO SUPPLEMENT STEM CELL TRANSPLANTATION A61K 35/14 (2006.01) EP 2097087 * SUPPRESSIVE MACROPHAGES, C-REACTIVE PROTEIN AND THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS AND IMMUNE THROMBOCYTOPENIC PURPURA A61K 35/38 (2006.01) EP 2089042 * METHODS FOR IMPROVED ENGRAFTMENT FOLLOWING STEM CELL TRANSPLANTATION A61K 35/44 (2006.01) EP 2089042 * METHODS FOR IMPROVED ENGRAFTMENT FOLLOWING STEM CELL TRANSPLANTATION A61K 35/74 (2006.01) EP 2022502 Lactobacillus rhamnosus and weight control A61K 35/76 (2006.01) EP 2097517 * MODIFIED VACCINIA VIRUS STRAINS FOR USE IN DIAGNOSTIC AND THERAPEUTIC METHODS A61K 36/185 (2006.01) EP 1886690 Pharmaceutical composition for the treatment of food intolerance A61K 36/185 (2006.01) EP 2094285 * SPECIAL EXTRACT, AND USE THEREOF FOR THE PREVENTION OF CYCLIC GUANOSINE MONOPHOSPHATE (CGMP) DECOMPOSITION A61K 36/23 (2006.01) EP 2088999 * PHARMACEUTICAL COMPOSITION COMPRISING AN ACTIVE INGREDIENT WHICH NEUTRALIZES AND/OR BINDS GASTRIC ACID, SUCH AS AN ALGINIC ACID DERIVATIVE A61K 36/328 (2006.01) EP 2088865 * GUGGULPHOSPHOLIPID METHODS AND COMPOSITIONS A61K 38/00 (2006.01) EP 2014296 Novel strategies for increasing the reperfusion in obstructed blood vessel A61K 38/00 (2006.01) EP 2086533 * USE OF AN ADENOSINE ANTAGONIST A61K 38/00 (2006.01) EP 2094726 * COMPOSITIONS AND METHODS RELATED TO TOLL-LIKE RECEPTOR-3 A61K 38/00 (2006.01) EP 2096167 * APTAMER AGAINST MIDKINE AND USE THEREOF A61K 38/00 (2006.01) EP 2098595 * HLA-A*1101-RESTRICTED WT1 PEPTIDE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME A61K 38/01 (2006.01) EP 2089046 * ANTIDIABETOGENIC CALCIUM-PEPTIDE COMPOSITION A61K 38/05 (2006.01) EP 2094720 * SELECTIVE INHIBITORS OF NEUROTENSIN DEGRADING ENZYMES A61K 38/06 (2006.01) EP 2086982 * HCV NS3 PROTEASE INHIBITORS ISSN 1331-2030
Page 1 and 2:
ISSN 1847-3024 HRVATSKI GLASNIK INT
Page 3 and 4:
HR - Sadržaj - Hrvatski glasnik in
Page 5 and 6:
HR - Dvoslovne oznake - Hrvatski gl
Page 7:
Objava podataka o intelektualnom vl
Page 11 and 12:
Prijave patenata i zahtjevi za priz
Page 13 and 14:
HR - Patenti - Hrvatski glasnik int
Page 15 and 16:
Page 17 and 18:
Page 19 and 20:
Page 21 and 22:
Page 23 and 24:
Page 25 and 26:
Page 27 and 28:
Page 29 and 30:
Priznati patenti/konsenzualni paten
Page 31 and 32:
Page 33 and 34:
Page 35:
Objava konsenzualnih patenata Objav
Page 38 and 39:
3402 HR - Patenti - Hrvatski glasni
Page 40 and 41:
Page 43 and 44:
Page 45:
Prestanak vrijednosti patenata/kons
Page 49:
PROŠIRENI EUROPSKI PATENTI
Page 52 and 53:
Objava zahtjeva za proširenje euro
Page 54 and 55:
Page 56 and 57:
Page 58 and 59:
Page 60 and 61:
Page 62 and 63:
Page 64 and 65:
Page 66 and 67:
Page 68 and 69:
Page 70 and 71:
Page 72 and 73:
Page 74 and 75:
Page 76 and 77:
Page 78 and 79:
Page 80 and 81:
Page 82 and 83:
Page 84 and 85:
Page 86 and 87:
Page 88 and 89:
Page 90 and 91:
Page 92 and 93:
Page 94 and 95: 3458 HR - Patenti - Hrvatski glasni
Page 194 and 195:
Page 196 and 197:
Page 198 and 199:
Page 200 and 201:
Page 202 and 203:
Page 204 and 205:
Page 206 and 207:
Page 208 and 209:
Page 210 and 211:
Page 212 and 213:
Page 215 and 216:
Prošireni europski patenti Objava
Page 217 and 218:
Page 219 and 220:
Page 221 and 222:
Page 223 and 224:
Page 225 and 226:
Page 227 and 228:
Page 229 and 230:
Page 231 and 232:
Page 233 and 234:
Page 235 and 236:
Page 237:
Page 241 and 242:
Prijave za registraciju žigova Obj
Page 243 and 244:
HR - Žigovi - Hrvatski glasnik int
Page 245 and 246:
Page 247 and 248:
Page 249 and 250:
Page 251 and 252:
Page 253 and 254:
Page 255 and 256:
Page 257 and 258:
Page 259 and 260:
Page 261 and 262:
Page 263 and 264:
Page 265 and 266:
Page 267 and 268:
Page 269 and 270:
Page 271 and 272:
Page 273 and 274:
Page 275 and 276:
Page 277 and 278:
Page 279 and 280:
Page 281 and 282:
Page 283 and 284:
Page 285 and 286:
Page 287 and 288:
Page 289 and 290:
Page 291 and 292:
Page 293 and 294:
Page 295 and 296:
Page 297 and 298:
Page 299 and 300:
Page 301 and 302:
Page 303 and 304:
Page 305 and 306:
Page 307 and 308:
Page 309 and 310:
Page 311 and 312:
Page 313 and 314:
Page 315 and 316:
Page 317 and 318:
Page 319 and 320:
Page 321 and 322:
Page 323 and 324:
Page 325 and 326:
Page 327 and 328:
Page 329 and 330:
Page 331 and 332:
Page 333 and 334:
Page 335 and 336:
Page 337 and 338:
Page 339 and 340:
Page 341 and 342:
Page 343 and 344:
Page 345 and 346:
Page 347 and 348:
Page 349 and 350:
Page 351 and 352:
Page 353:
Page 357 and 358:
Page 359 and 360:
Page 361 and 362:
Page 363 and 364:
Page 365 and 366:
Page 367 and 368:
Page 369 and 370:
Page 371 and 372:
Page 373 and 374:
Page 375 and 376:
Registrirani žigovi Objava žigova
Page 377 and 378:
Page 379 and 380:
Page 381 and 382:
Page 383 and 384:
Page 385 and 386:
Page 387 and 388:
Page 389 and 390:
Page 391 and 392:
Page 393 and 394:
Page 395 and 396:
Page 397 and 398:
Page 399 and 400:
Page 401 and 402:
Page 403 and 404:
Page 405 and 406:
Page 407 and 408:
Page 409 and 410:
Page 411 and 412:
Page 413 and 414:
Page 415 and 416:
Page 417 and 418:
Page 419 and 420:
Page 421 and 422:
Page 423 and 424:
Page 425 and 426:
Page 427 and 428:
Page 429 and 430:
Page 431 and 432:
Page 433 and 434:
Page 435 and 436:
Page 437 and 438:
Page 439 and 440:
Page 441:
Produženje vrijednosti registracij
Page 444 and 445:
3808 HR - Žigovi - Hrvatski glasni
Page 446 and 447:
Page 449 and 450:
Page 451:
Industrijska obličja/ industrijski
Page 455:
HR - Industrijska obličja/dizajn -
Page 458 and 459:
Objava registracija industrijskoga
Page 460 and 461:
3824 HR - Industrijska obličja/diz
Page 462 and 463:
Page 464 and 465:
Page 466 and 467:
Page 468 and 469:
Page 470 and 471:
Page 472 and 473:
Page 475:
Page 479 and 480:
Page 481:
Page 484 and 485:
Informacije o objavama međunarodni
Page 486 and 487:
Page 488 and 489:
Page 490 and 491:
Page 493:
HR - Hrvatski glasnik intelektualno
Page 497 and 498:
HR - Informacijski proizvodi i uslu
Page 499 and 500:
Page 501 and 502:
Page 503 and 504:
Page 505:
Page 509 and 510:
HR - Popis zastupnika registriranih
show all

09/2009 - DrÅ¾avni zavod za intelektualno vlasniÅ¡tvo

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?